Iodine-124-AVP 0458

Drug Profile

Iodine-124-AVP 0458

Alternative Names: 124I-PEG-AVP04; AVP-04 - Avipep; AVP-4; I124-AVP 04

Latest Information Update: 08 Apr 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Avipep
  • Class Antibody diagnostics; Imaging agents; Polyethylene glycols; Radiopharmaceutical diagnostics; Radiopharmaceuticals
  • Mechanism of Action Positron-emission tomography enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Phase I Ovarian cancer; Prostate cancer

Most Recent Events

  • 29 Aug 2012 Phase-I clinical trials in Ovarian cancer (Diagnosis) in Australia (IV)
  • 29 Aug 2012 Phase-I clinical trials in Prostate cancer (Diagnosis) in Australia (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top